Cargando…
Cost Consequence Analysis of Belimumab versus Standard of Care for the Management of Systemic Lupus Erythematosus in Saudi Arabia: A Retrospective Cohort Study
Background: Belimumab use for the management of systemic lupus erythematosus (SLE) has been limited, in part due to its high acquisition cost relative to the standard of care (SoC) and the uncertainties about its cost-effectiveness. Therefore, the aim of this study was to compare the cost and effect...
Autores principales: | Alsuwayegh, Aseel, Almaghlouth, Ibrahim A., Almasaoud, Majed Ali, Alzaid, Abdullah Sulaiman, Alsuhaibani, Adel Abdulaziz, Almana, Lyan Hassan, Alabdulkareem, Sara Mohammed, Abudahesh, Joud Abdullah, AlRuthia, Yazed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9915237/ https://www.ncbi.nlm.nih.gov/pubmed/36767283 http://dx.doi.org/10.3390/ijerph20031917 |
Ejemplares similares
-
Community Pharmacists’ Views of the Enforced Antibiotics Dispensing Law and Its Impact on Oral Antibiotics Sales in Saudi Arabia
por: AlRukban, Mohammed, et al.
Publicado: (2020) -
How can Saudi Arabia reform its public hospital payment models? A narrative review
por: AlRuthia, Yazed, et al.
Publicado: (2020) -
The impact of Hydroxyurea on the rates of Vaso–occlusive crises in patients with sickle cell disease in Saudi Arabia: a single–center study
por: Alkhalifah, Sahar Abdullah, et al.
Publicado: (2022) -
The status of licensed pharmacy workforce in Saudi Arabia: a 2030 economic vision perspective
por: AlRuthia, Yazed, et al.
Publicado: (2018) -
The characteristics and distribution of emergency medical services in Saudi Arabia
por: Al-Wathinani, Ahmed M., et al.
Publicado: (2023)